The DTNBP1 Knockout HeLa Polyclonal Cells represent a well-defined CRISPR/Cas9-edited polyclonal population derived from the HeLa cell line, in which the DTNBP1 gene has been disrupted to ablate dysbindin expression. This polyclonal knockout model offers a heterogeneous pool of edited alleles, providing a robust system for studying loss-of-function phenotypes without the biases associated with single-cell clonal selection. The targeted disruption of DTNBP1 enables researchers to dissect the contributions of dysbindin to BLOC-1 complex function in a reproducible cellular background.
The HeLa host cell line is an immortalized human cervical adenocarcinoma cell line positive for human papillomavirus type 18 (HPV18). Its rapid proliferation, ease of culture, and extensive characterization make it a widely adopted model in cell biology, cancer research, and trafficking studies. Despite its non-neuronal origin, HeLa cells express key components of the BLOC-1 machinery and have been utilized to investigate lysosome-related organelle biogenesis and vesicular trafficking, thus providing a relevant context for DTNBP1 functional analysis.
DTNBP1 encodes dysbindin, a core subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1). Dysbindin directly interacts with other BLOC-1 components including BLOC1S1, BLOC1S2, SNAPIN, MUTED, PLDN, and CNO, as well as with dystrobrevin. The BLOC-1 complex is regulated upstream by transcription factors such as PAX6 and SOX10, and it orchestrates the trafficking of lysosome-related organelles and synaptic vesicles by modulating downstream effectors including TYRP1, LAMP1, and the dopamine D2 receptor (DRD2), along with the actin cytoskeleton. Knockout of DTNBP1 disrupts BLOC-1 assembly and function, impairing organelle biogenesis and recycling of neurotransmitter receptors, thereby affecting dopaminergic signaling and synaptic plasticity.
In the context of HeLa cells, DTNBP1 knockout provides a simplified yet informative model to study BLOC-1-dependent trafficking pathways without the complexity of neuronal systems. This model is particularly valuable for teasing apart the molecular interactions that govern lysosome-related organelle formation and for investigating how dysbindin deficiency contributes to disease states such as Hermansky-Pudlak syndrome type 7, schizophrenia, and bipolar disorder. By uncoupling BLOC-1 function from neuron-specific effects, researchers can focus on fundamental cellular mechanisms that may underlie neuropsychiatric and syndromic disorders.
Typical research applications employing these polyclonal knockout cells include co-immunoprecipitation and immunoblotting to assess BLOC-1 complex integrity, immunofluorescence microscopy to monitor LAMP1-positive lysosome-related organelle distribution, flow cytometry to quantify surface DRD2 levels, and neurotransmitter release assays to evaluate secretory pathway alterations. These cells are also suited for high-content screening and functional rescue experiments to dissect the role of individual BLOC-1 subunits. For further details and custom project inquiries, please contact Ascent Research.
